Browsing: Amgens

Wellness Tips

Watch Out, Eli Lilly and Novo Nordisk: Amgen’s Monthly Weight Loss Drug Has 6 Phase 3 Trials Running — and It’s Coming for Your Patients

By 0

Amgen(NASDAQ: AMGN) is betting that the convenience of its weight loss treatment will make it a winner, and it might be right. Its candidate MariTide is a monthly injection that aims to directly challenge the anti-obesity drugs made by Eli Lilly(NYSE: LLY) and Novo Nordisk(NYSE: NVO), which in their original formulations are administered by a…